GE Healthcare and Sealed Air to develop film for single-use bioprocess systems

18 August 2016 (Last Updated August 18th, 2016 18:30)

US-based primary films producer Sealed Air has expanded a strategic alliance with GE Healthcare’s Life Sciences business to develop new films for single-use bioprocess systems.

US-based primary films producer Sealed Air has expanded a strategic alliance with GE Healthcare’s Life Sciences business to develop new films for single-use bioprocess systems.

Under the long-term deal, both GE and Sealed Air have already developed a new film that can be used across GE’s single-use portfolio.

 GE Healthcare Life Sciences upstream products GM Morgan Norris said: “GE and Sealed Air share a vision of the importance of robust, high-quality films in the efficient manufacture of life-saving medicines, such as monoclonal antibodies, vaccines and next-generation biotherapeutics.

"Through this partnership we are confident that we will deliver the next level of purposefully constructed and manufactured films for bioprocessing applications."

“Through this partnership we are confident that we will deliver the next level of purposefully constructed and manufactured films for bioprocessing applications, enabling improved performance, supply chain control, and material / supplier transparency that the market demands of single-use suppliers.”

Sealed Air’s medical applications business manufactures films for pharmaceutical solutions and barrier films for stoma and ostomy pouches under the Nexcel brand.

The company currently employs around 23,000 people and serves customers in 169 countries.

In May, Sealed Air entered a strategic partnership with Box on Demand and Panotec to create on-demand boxes, in order to help reduce waste, freight cost and carbon emissions.

Both Box on Demand and Panotec provide three-dimensional equipment platforms and fanfold corrugated materials.